Parnassus Investments’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-254,621
Closed -$32.4M 156
2025
Q1
$32.4M Sell
254,621
-111,611
-30% -$17.2M 0.08% 103
2024
Q4
$52.7M Sell
366,232
-15,239
-4% -$2.19M 0.12% 94
2024
Q3
$56.8M Sell
381,471
-7,060
-2% -$1.01M 0.12% 92
2024
Q2
$49M Buy
388,531
+108
+0% +$16.9K 0.11% 95
2024
Q1
$71.4M Sell
388,423
-161,701
-29% -$30.8M 0.15% 91
2023
Q4
$98.9M Hold
550,124
0.22% 80
2023
Q3
$87.5M Buy
+550,124
New +$89.9M 0.21% 84

Other funds holding RGEN

Parnassus Investments's RGEN Position: Q2 2025 in Review

Parnassus Investments sold out of Repligen (RGEN) in Q2 2025, closing a stake of 254,621 shares — an estimated $32.4M sold.

Parnassus Investments first reported a position in RGEN in Q3 2023 and held it in 7 quarters. The position peaked at $98.9M in Q4 2023. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Parnassus Investments reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Parnassus Investments sold 254,621 Repligen shares in Q2 2025, an estimated $32.4M.
  • Parnassus Investments first reported a position in Repligen in Q3 2023 and held it in 7 quarters.
  • Parnassus Investments's Repligen position peaked at $98.9M in Q4 2023.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Parnassus Investments's 13F filing for Q2 2025, filed 6 Aug 2025.